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Abstract 
Previously we observed strong positive associations between circulating concentrations 
of free testosterone and free dihydrotestosterone (DHT) in relation to Barrett’s esophagus 
in a US male military population. To replicate these findings, we conducted a second 
study of sex steroid hormones and Barrett’s esophagus in the Factors Influencing the 
Barrett/Adenocarcinoma Relationship (FINBAR) Study based in Northern Ireland and 
Ireland. We used mass spectrometry to quantitate EDTA plasma concentrations of nine 
sex steroid hormones and ELISA to quantitate sex hormone binding globulin in 177 male 
Barrett’s esophagus cases and 185 male general population controls within the FINBAR 
Study. Free testosterone, free DHT, and free estradiol were estimated using standard 
formulas. Multivariable logistic regression estimated odds ratios (OR) and 95% 
confidence intervals (95%CI) of associations between exposures and Barrett’s esophagus. 
While plasma hormone and sex hormone binding globulin concentrations were not 
associated with all cases of Barrett’s esophagus, we did observe positive associations 
with estrogens in younger men (e.g., estrone + estradiol ORcontinuous per ½ IQR=2.92, 
95%CI:1.08, 7.89), and free androgens in men with higher waist-to-hip ratios (e.g., free  
testosterone ORcontinuous per ½ IQR=2.71, 95%CI:1.06, 6.92). Stratification by body mass 
index, antireflux medications, and geographic location did not materially affect the 
results. This study found evidence for associations between circulating sex steroid 
hormones and Barrett’s esophagus in younger men and men with higher waist-to-hip 
ratios. Further studies are necessary to elucidate whether sex steroid hormones are 
consistently associated with esophageal adenocarcinogenesis. 
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Introduction 
During the natural history of esophageal adenocarcinoma from reflux, to Barrett’s 
esophagus to cancer, the male-to-female sex ratio progressively increases, culminating in 
more than seven males for every female with cancer (Cook et al. 2005, Cook et al. 2009).  
This stark sex disparity has been repeatedly observed, yet underlying causes have not 
been identified (Cheng et al. 2000, Lindblad et al. 2005, Lofdahl et al. 2008, Cook et al. 
2010, Rutegard et al. 2010, Bodelon et al. 2011, Freedman et al. 2011, Cook et al. 2012, 
Hoyo et al. 2012, Kubo et al. 2013, Cook et al. 2014). Sex steroid hormones have been 
hypothesized to be a possible cause (Lagergren et al. 1998) and the fact that sex steroid 
hormones are involved in inflammatory processes (Maggio et al. 2005, Schmidt et al. 
2006, Kupelian et al. 2010, Liao et al. 2012) and that sex steroid hormone receptor 
proteins are expressed in esophageal tissues (Rashid et al. 2010, Yang et al. 2012) 
support such a proposition. This motivated us to conduct an analysis of sex steroid 
hormones in relation to Barrett’s esophagus in a US male military population in which we 
observed strong positive associations with circulating concentrations of free testosterone 
and free dihydrotestosterone (DHT) (Cook et al. 2014). To replicate these findings, we 
have conducted a second study of sex steroid hormones and Barrett’s esophagus in the 
Factors Influencing the Barrett/Adenocarcinoma Relationship (FINBAR) Study.    
 
Materials and Methods 
Study Population 
The FINBAR Study has been described in detail elsewhere (Anderson et al. 2006). In 
brief, the study recruited incident and prevalent long segment (≥3 cm) Barrett’s 
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esophagus cases, incident esophageal adenocarcinoma cases, and population controls 
during 2002–2004 in Northern Ireland and Ireland. All cases and controls in the FINAR 
Study were Caucasian. Barrett’s esophagus cases were required to have histologic 
confirmation of specialized intestinal metaplasia from biopsy specimens. Patients with 
dysplasia were not included. In Northern Ireland, Barrett’s esophagus cases were initially 
identified from pathology reports gathered from throughout Northern Ireland. Endoscopy 
note review was necessary in most patients to confirm long segment Barrett’s esophagus. 
In the Republic of Ireland, clinicians in the Dublin and Cork areas sent details of Barrett’s 
esophagus patients who met the inclusion criteria to the research personnel. Eligible 
control subjects for the FINBAR Study were adults without a prior diagnosis of Barrett’s 
esophagus, esophageal cancer, or other gastrointestinal cancer. Eligible Northern Ireland 
controls were individuals listed in the General Practice Master Index (a province-wide 
database of all persons registered with a general practitioner). Eligible Republic of 
Ireland controls were individuals listed with one of four general practices (two urban and 
two rural) in the Dublin and Cork areas. For the primary FINBAR Study, population 
controls and Barrett’s esophagus cases were each frequency-matched by region, sex, and 
5-year age groups to the esophageal adenocarcinoma case group. 
After giving written informed consent, each study participant underwent a 
structured computerized interview with a trained interviewer. Demographic, exposure, 
and medical information were ascertained. Frequent gastroesophageal reflux was defined 
as symptoms of heartburn and/or acid reflux occurring at least once weekly (>50 times 
per year) >5 years before interview. Subjects were classified as having gastroesophageal 
reflux if they responded positively to either of the following questions: (a) Have you ever 
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had frequent heartburn (i.e., a burning or ache behind the breastbone that is not due to 
heart problems) not including the last 5 years? or (b) Have you ever had frequent acid 
reflux (i.e., a bitter taste of stomach acid, which has come up to the back of your throat) 
not including the last 5 years? Current smoking status was defined as smokers who had 
smoked at least one cigarette daily for ≥6 months 5 years before interview date. Previous 
smokers were those smokers who had quit smoking >5 years before interview date. 
People who had never smoked, who had smoked <100 cigarettes in their lifetime, or who 
had smoked <1 cigarette daily for <6 months were defined as never smokers. Alcohol 
consumption was measured using the European Prospective Investigation of Cancer food 
frequency questionnaire developed for the Norfolk area of England (Day et al. 1999). 
Alcohol consumption 5 years before interview date was defined as the number of grams 
of alcohol consumed daily. At the interview visit, height, weight and waist-to-hip ratio 
were measured by the interviewer. In addition, a 30 ml sample of peripheral venous blood 
(non-fasting) was taken, transported on ice, and then—for 97% of subjects—centrifuged 
within 5 hours (the maximum time between blood draw and centrifugation was 12 hours). 
Serum, plasma, and buffy coat were stored at −80°C. EDTA plasma samples were used 
for quantitation of circulating sex steroid hormones and SHBG. For this analysis of 
circulating hormones, comparing Barrett’s esophagus cases to population controls, the 
study population was restricted to males because there were too few females to provide 
adequate statistical power for a female-only analysis. 
 
Laboratory analysis 
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In collaboration with the Pharmacogenomics Laboratory of Laval University, Quebec, 
Canada, we quantitatively assessed: dehydroepiandrosterone (DHEA), androstenediol, 
androstenedione, progesterone, testosterone, dihydrotestosterone (DHT), androsterone 
(ADT), estrone and estradiol using gas chromatography–mass spectrometry (GC-MS); 
and sex hormone binding globulin (SHBG) using ELISA (Diagnostics Biochem Canada, 
Inc.). These selected sex steroid hormones cover a wide array and key positions of the 
sex steroid biosynthesis pathway (Figure). Three low hormone concentration quality 
control replicates and three high hormone concentration quality control replicates were 
included in each of the nine batches. All metabolite coefficients of variation (CV) were 
less than 10% (range: 3.5–8.8%; Supplementary Table 1). Further information on the 
methods can be found in our recent publication.(Caron et al. 2015) 
 
Statistical Analysis 
Participant characteristics of Barrett’s esophagus cases were compared with controls 
using the t-test for continuous variables and the chi-squared test for categorical variables. 
Partial correlation coefficients adjusted for age at interview (continuous) and body mass 
index (BMI, kg/m2) at interview (continuous) were calculated using population controls. 
Univariate linear regressions and univariate logistic regressions were conducted to assess 
whether study participant variables were associated with log hormone concentrations and 
with case-control status. Study participant variables assessed included age at interview 
(quartiles), education (<10, 10–12, 13–20 years), occupation (non-manual/manual), BMI 
at interview (<25, 25–<30, ≥30 kg/m2), waist-to-hip ratio (<0.97, ≥0.97)  
gastroesophageal reflux symptoms (yes/no), ever-cigarette smoking status (ever/never), 
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alcohol consumption (<6.3, 6.3–23.1, 23.2–44, ≥44.1 g/day) physical activity (not at all 
active/not very active/fairly active), and serologic Helicobacter pylori (H. pylori) status 
(positive/negative) (Anderson et al. 2008). Hormone concentrations were assessed as 
quartiles using cutpoints based on population control distributions, as well as continuous 
variables with standardization to half the value of the interquartile range (which 
approximates a single quartile increase in exposure).  In addition to assessing individual 
hormone exposures, we also assessed a priori specified combinations and ratios of 
hormones that are in close proximity within the metabolic pathway: parent estrogens (the 
sum of estrone and estradiol), testosterone:parent estrogens ratio, testosterone:estradiol 
ratio, and androstenedione:estrone ratio. We calculated free estradiol (Sodergard et al. 
1982), free testosterone (Vermeulen et al. 1999), and free DHT (Starka et al. 2009) using 
formulas that include the individual hormone, SHBG, and a constant for albumin.  
Variables that were associated with Barrett’s esophagus cases and with at least 
one exposure were considered as potential confounding variables and were entered into 
an age-adjusted multivariable stepwise logistic regression with entrance p value set at 
0.05 and removal p value set at 0.10 in order to estimate ORs and 95% confidence 
intervals (95%CI). Adjusted logistic regression models, using stepwise selection, resulted 
in adjustment for age (quartiles), gastroesophageal reflux symptoms (yes/no) and H. 
pylori seropositivity (yes/no). We also conducted a “fully adjusted” model which 
included age (categorical), ever-cigarette smoking status, alcohol consumption 
(categorical), BMI at diagnosis (categorical), and gastroesophageal reflux disease 
symptoms in consideration of previous evidence that these exposures are associated with 
Barrett’s esophagus. We also assessed whether relationships between exposures and 
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Barrett’s esophagus were modified by age, BMI, waist-to-hip ratio, waist circumference, 
proton pump inhibitor use, H2 receptor antagonist use, and geographic location (Northern 
Ireland/Ireland) by conducting stratified analyses. Exposures were modelled as both 
categorical and continuous variables in this assessment of effect modification. The 
likelihood ratio test was used to assess whether strata were statistically significantly 
different to one another. All tests were two-sided and p-values <0.05 were considered to 
be statistically significant.  Analyses were conducted using STATA version 13.1 (Stata-
Corp LP, College Station, TX). 
 
Results 
Descriptive characteristics of male Barrett’s esophagus cases and male population 
controls were largely similar (Table 1). Notable differences existed for gastroesophageal 
reflux disease symptoms (72% Barrett’s vs 20% controls; p<0.001), H. pylori positivity 
(44% vs 63%; p<0.001), and manual occupation (61% vs 51%; p=0.046).  
 Partial correlation coefficients adjusted for age and BMI at interview using the 
control population were strongest for estradiol and free estradiol (0.86), testosterone and 
DHT (0.72), DHT and free DHT (0.68), free testosterone and free DHT (0.64), and 
estradiol and estrone (0.63) (Supplementary Table 2).  
The primary statistical models, adjusted for age at interview, gastroesophageal 
reflux symptoms and H. pylori seropositivity, are shown in Table 2. None of the 
hormones or SHBG demonstrated a consistent association with Barrett’s esophagus. 
Additional adjustment for ever-cigarette smoking status and alcohol consumption had no 
material effect on the results obtained (Supplementary Table 3).  
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Upon stratified analysis, age did appear to be an effect modifier of hormone-
Barrett’s esophagus associations, with estrone (ORcontinuous=2.53, 95%CI: 1.07, 5.97), 
estradiol (ORcontinuous=2.11, 95%CI: 0.80, 5.56), the sum of these estrogens (parent 
estrogens: ORcontinuous=2.92, 95%CI:1.08, 7.89), and free estradiol (ORcontinuous=2.66, 
95%CI:0.96, 7.38) providing evidence of associations with Barrett’s esophagus in 
younger aged (<65.9 years) men, but not in older aged men (Table 3 and Supplementary 
Table 4). However, older aged men did appear to exhibit an association between 
androstenedione:estrone ratio (ORcontinuous=2.82, 95%CI: 1.15, 6.93) which was absent in 
younger men. BMI was not an effect modifier of hormone-Barrett’s esophagus 
associations (data not shown) but waist-to-hip ratio was (Table 4 and Supplementary 
Table 5). In men with a waist-to-hip ratio greater than or equal to the median (0.97), free 
testosterone (ORcontinuous=2.71, 95%CI:1.06, 6.92) and free DHT (ORcontinuous=2.66, 
95%CI:1.29, 5.48) were each positively associated with Barrett’s esophagus. Stratified 
analyses by waist circumference (Supplementary Table 6), proton pump inhibitor use, H2 
receptor antagonist use, and geographic location (Northern Ireland/Ireland) did not affect 
results obtained (unless specified, results not shown). Adjustment for age continuous 
instead of age categorical had negligible effects on the analyses conducted. 
 
Discussion with Conclusions 
In this study of participants from the island of Ireland, we find no overall association 
between circulating sex steroid hormone concentrations and Barrett’s esophagus in 
males. Barrett’s esophagus was, however, positively associated with estrogens in younger 
men and free androgens in men with higher waist-to-hip ratios. The latter associations—
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in which free testosterone and free DHT each demonstrated strong, dose-response 
associations with Barrett’s esophagus—concur with the results of the overall analysis of 
our previous US-based study (Cook et al. 2014).  
The positive results of our prior US-study were due to a combination of higher 
concentrations of testosterone and DHT and lower concentrations of SHBG in cases 
relative to controls. In this analysis based within the FINBAR Study, free testosterone 
and DHT were only associated with BE for men with higher waist-to-hip ratios. The 
reason for this is unclear and waist-to-hip ratio was not available in our previous US 
study. It is possible that the associations within the prior US study would have been 
stronger—or restricted to—men with a higher waist-to-hip ratio, and that the overall 
analysis was also positive because of higher waist-to-hip ratios. This idea has support 
from the fact that the mean BMI values were slightly higher for cases (28.4) and for 
controls (28.4) in the prior US study relative to the study presented here, and this was 
despite the younger mean ages of the prior study. Although no associations were 
observed in the present study when stratified by BMI or waist circumference, waist-to-
hip ratio is the highest anthropometric correlate of visceral adipose tissue/subcutaneous 
adipose tissue ratio in men (Bazzocchi et al. 2014) and both of these fat depots have been 
implicated in risk of Barrett’s esophagus, with waist circumference positively associated 
(Kubo et al. 2013) and hip circumference inversely associated (Kendall et al. 2016). 
Similar effects have been noted for esophageal adenocarcinoma (Steffen et al. 2015). 
Visceral adipose tissue is known to have a high metabolic rate with detrimental 
consequences on health (Walker et al. 2014). Conversely, gluteofemoral adipose tissue 
has been postulated to act as metabolic sink, reducing concentrations of adipocytokines, 
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insulin and carbohydrates (Manolopoulos et al. 2010). Thus it is conceivable that waist-
to-hip ratio—as a proxy of these underlying exposures—modifies associations between 
sex steroid hormones and Barrett’s esophagus. The slight age differences between the 
studies is unlikely to explain the differences in free androgen-Barrett’s esophagus 
associations, given that age was not an effect modifier of these associations in either 
population. In addition, the findings are unlikely to differ due to a technicality given that 
the same laboratory, personnel, machines and assays were used for both studies.  
Another possible reason for the slight differences in results of our two studies is 
the use of different control groups—population controls in this study and endoscopy-
negative controls in the prior US-study. Our original hypothesis—that the inverse 
associations between androgens and wound healing (Ashcroft et al. 2002, Engeland et al. 
2009, Gilliver et al. 2009) may expand the interval for opportunistic metaplastic re-
population—may be better tested using endoscopy-negative (or even reflux-positive) 
controls, as opposed to the population controls used in this study. Further studies 
comparing Barrett’s esophagus cases with both types of control groups may help further 
elucidate any consistent relationship between free androgens and Barrett’s esophagus. 
Other factors that differ between the studies that could underlie the contrasting 
results of the main analyses include different countries (Northern Ireland & Ireland vs 
United States), different underlying population types (general population vs military), and 
different specimen types (EDTA plasma vs serum). Although circulating androgen and 
SHBG concentrations have been quantitated in healthy US men, no study has published 
on such concentrations using healthy men from Northern Ireland or Ireland. In general, 
age-specific concentrations of androgens were lower and SHBG was higher in this 
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population relative to the US population of the prior study. Regardless, any differences in 
hormone levels due to the underlying population would be unlikely to explain the relative 
case-control differences between studies. This is also true for the different specimen 
types used, despite few studies of the comparability of blood hormone levels from plasma 
and serum samples.  
Strengths of this study include the use of a robust quantitative technology for 
quantitation of sex steroid hormones and a sample size more than adequate to detect the 
magnitude of associations we reported in our prior study. A limitation is the fact that we 
did not have an endoscopy-negative or gastroesophageal reflux disease control 
population, which would have provided for a more direct comparison with our prior US-
study. In addition, statistical power was less for stratified analyses in which associations 
have been detected and future studies should be designed with these findings in mind. 
In summary, this study found evidence that Barrett’s esophagus was positively 
associated with estrogens in younger men and positively associated with free androgens 
in men with higher waist-to-hip ratios. Additional studies of esophageal 
adenocarcinogenesis are warranted to further elucidate the hypothesis that sex steroid 
hormones may underlie the stark sex differences of this disease.  
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Figure. Schematic of Sex Steroid Hormone Metabolism. 
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Figure Legend: Sex steroid hormones that were quantitated are shown in blue font. Note that Sex Hormone Binding Globulin 
(SHBG) is not shown as it is not a part of the sex steroid biosynthesis pathway. Abbreviations: 3α-diol, 3-androstanediol; 3α-diol-G, 
3-androstanediol glucuronide; ADT, androsterone; ADT-G, androsterone glucuronide; DHEA, dehydroepiandrosterone; DHEAS, 
dehydroepiandrosterone-sulphate; DHT, dihydrotestosterone. 
 
 
